Kangji Medical Holdings Limited (9997.HK)
HKD 6.52
(-1.21%)
HKD 6.52
(-1.21%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 926.02 Million | 786.36 Million | 690.26 Million | 511.49 Million | 503.46 Million | 353.67 Million |
| Cost of Revenue | 184.82 Million | 151.12 Million | 127.33 Million | 80.02 Million | 80.29 Million | 64.37 Million |
| Gross Profit | 741.19 Million | 635.24 Million | 562.92 Million | 431.47 Million | 423.17 Million | 289.29 Million |
| Operating Expenses | 298.72 Million | 140.23 Million | 79.81 Million | 138.49 Million | 48.67 Million | 40.74 Million |
| Selling, General and Administrative Expenses | 171.17 Million | 123.21 Million | 109.18 Million | 94.58 Million | 67 Million | 33.09 Million |
| Research and Development Expenses | 127.55 Million | 66.01 Million | 36 Million | 25.22 Million | 17.37 Million | 14.85 Million |
| Other Expenses | - | -26.46 Million | -3.69 Million | -25.55 Million | -1.15 Million | 61 Thousand |
| Cost and Expenses | 483.55 Million | 291.35 Million | 207.15 Million | 218.51 Million | 128.96 Million | 105.11 Million |
| Operating Income | 442.47 Million | 446.01 Million | 417.73 Million | 311.66 Million | 338.79 Million | 260.54 Million |
| Interest Expense | 2.25 Million | 1.87 Million | 196 Thousand | 42 Thousand | - | 2000.00 |
| Income Tax Expense | 136.47 Million | 101.97 Million | 77.7 Million | 50.92 Million | 64.45 Million | 37.36 Million |
| Earnings before Tax | 588.77 Million | 563.14 Million | 534.49 Million | 310.07 Million | 391.19 Million | 261.15 Million |
| Net Income | 504.02 Million | 478.73 Million | 456.78 Million | 250.29 Million | 206.44 Million | 146.7 Million |
| Earnings Per Share Basic | 0.43 | 0.40 | 0.37 | 0.26 | 0.20 | 0.12 |
| Earnings Per Share Diluted | 0.43 | 0.40 | 0.37 | 0.26 | 0.20 | 0.12 |
| Weighted Average Shares Outstanding | 1.17 Billion | 1.2 Billion | 1.22 Billion | 952.79 Million | 1.02 Billion | 1.25 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.17 Billion | 1.2 Billion | 1.23 Billion | 963.77 Million | 1.02 Billion | 1.25 Billion |
| Gross Margin | 0.80 | 0.81 | 0.82 | 0.84 | 0.84 | 0.82 |
| EBIT Margin | 0.50 | 0.59 | 0.62 | 0.62 | 0.69 | 0.75 |
| Profit Margin | 0.54 | 0.61 | 0.66 | 0.49 | 0.41 | 0.41 |
| EBITDA | 464.58 Million | 586.65 Million | 427.25 Million | 319.14 Million | 345.19 Million | 267.42 Million |
| Earnings Before Tax Margin | 0.48 | 0.57 | 0.61 | 0.61 | 0.67 | 0.74 |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 458.41 Million | 926.02 Million | 522.43 Million | 403.58 Million | 786.36 Million | 454.04 Million |
| Cost of Revenue | 95.29 Million | 184.82 Million | 102.99 Million | 81.83 Million | 151.12 Million | 84.51 Million |
| Gross Profit | 363.12 Million | 741.19 Million | 419.44 Million | 321.75 Million | 635.24 Million | 369.53 Million |
| Operating Expenses | 132.42 Million | 240.22 Million | 159.03 Million | 91.93 Million | 140.23 Million | 43.49 Million |
| Selling, General and Administrative Expenses | 89.07 Million | - | 91.55 Million | 79.61 Million | - | 66.05 Million |
| Research and Development Expenses | 43.35 Million | - | 67.47 Million | 60.07 Million | - | 39.73 Million |
| Other Expenses | - | -6.38 Million | - | - | -26.46 Million | - |
| Cost and Expenses | 227.71 Million | 425.04 Million | 262.02 Million | 173.76 Million | 291.35 Million | 128 Million |
| Operating Income | 230.69 Million | 442.47 Million | 260.4 Million | 182.06 Million | 446.01 Million | 263.73 Million |
| Interest Expense | - | 2.25 Million | - | - | 1.87 Million | - |
| Income Tax Expense | 52.04 Million | 136.47 Million | 94.49 Million | 41.98 Million | 101.97 Million | 60.67 Million |
| Earnings before Tax | 327.73 Million | 588.77 Million | 317.48 Million | 271.28 Million | 563.14 Million | 368.35 Million |
| Net Income | 285.84 Million | 504.02 Million | 248.56 Million | 255.46 Million | 478.73 Million | 321.02 Million |
| Earnings Per Share Basic | 0.24 | - | 0.21 | 0.22 | - | 0.27 |
| Earnings Per Share Diluted | 0.24 | - | 0.21 | 0.22 | - | 0.27 |
| Weighted Average Shares Outstanding | 1.17 Billion | 1.17 Billion | 1.16 Billion | 1.17 Billion | 1.2 Billion | 1.19 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.17 Billion | 1.17 Billion | 1.16 Billion | 1.17 Billion | 1.2 Billion | 1.19 Billion |
| Gross Margin | 0.79 | 0.80 | 0.80 | 0.80 | 0.81 | 0.81 |
| EBIT Margin | 0.53 | - | 0.52 | 0.48 | - | 0.60 |
| Profit Margin | 0.62 | 0.54 | 0.48 | 0.63 | 0.61 | 0.71 |
| EBITDA | 240.7 Million | - | 271.73 Million | 192.84 Million | - | 271.73 Million |
| Earnings Before Tax Margin | 0.50 | 0.48 | 0.50 | 0.45 | 0.57 | 0.58 |
ENX
115450
RIAS-B
6269
HAIS
6262